BLK vs EDIT · P/E 27, rev $24.22B vs rev $32.3M
BlackRock Inc (BLK) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the BLK and EDIT stock pages for the full models.
Not investment advice.